Stay updated on FAK-PD1 Inhibition Clinical Trial

Sign up to get notified when there's something new on the FAK-PD1 Inhibition Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FAK-PD1 Inhibition Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.8.0 to v3.8.1; the study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T02:47:05.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record describes a Phase I/IIa trial combining defactinib and pembrolizumab for advanced solid malignancies, including pancreatic cancer, NSCLC, and mesothelioma. It provides study design, eligibility criteria, outcome measures, and contact and location details.
    Difference
    74%
    Check dated 2026-11-11T01:53:34.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:14:40.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    An NIH announcement about terminology changes appears above the 403 error page, and the site revision label updates from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:21:46.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:18:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Access to the study record now renders a 403 Forbidden error page, replacing the previous study details with a standard error layout. This indicates an access restriction rather than an update to the study content.
    Difference
    21%
    Check dated 2026-09-23T00:44:57.000Z thumbnail image

Stay in the know with updates to FAK-PD1 Inhibition Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FAK-PD1 Inhibition Clinical Trial page.